A maker of digital health tools that connect drugmakers with doctors and patients inside the electronic health record (EHR) software clinicians already use. Its platform lets pharmaceutical brands send doctors practical messages at the moment of prescribing—covering new therapies, medication adherence, and copay assistance. Founded in 2006 by entrepreneur David A. Harrell, the company got its name from its mission to "optimize" the prescription (Rx) process, and it grew out of an earlier firm renamed in 2008. Its point-of-care messaging appears in thousands of EHR and e-prescribing systems used across the country.
Select a row to see that insider’s individual transactions. † Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: +324.7K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.